Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Quest Diagnostics
DGX
$26.2B
| $89.6M | 0.13% |
637,600
-33,800
| -5% | -$4.66M |
|
177
InMode
INMD
$870M
| $89.5M | 0.13% |
2,394,962
-26,800
| -1% | -$936K |
|
178
Qualcomm
QCOM
$171B
| $89M | 0.13% |
747,360
-689,700
| -48% | -$79.3M |
|
179
AstraZeneca
AZN
$246B
| $88.9M | 0.13% |
620,982
-484,019
| -44% | -$71.2M |
|
|
MOMO
180
Hello Group
MOMO
$861M
| $88.6M | 0.13% |
9,216,674
+98,476
| +1% | +$865K |
|
181
Kinder Morgan
KMI
$70.1B
| $88.1M | 0.13% |
5,115,231
+2,502,600
| +96% | +$42.5M |
|
182
TransDigm Group
TDG
$68.7B
| $87.5M | 0.13% |
97,800
+13,500
| +16% | +$10.7M |
|
183
Coupang
CPNG
$29.7B
| $87.3M | 0.13% |
5,016,600
-2,239,100
| -31% | -$36.5M |
|
184
Stanley Black & Decker
SWK
$15.7B
| $87.2M | 0.13% |
930,162
-622,800
| -40% | -$51.6M |
|
|
XYZ
185
Block Inc
XYZ
$47.5B
| $86.6M | 0.12% |
+1,300,300
| New | +$81.2M |
|
186
ResMed
RMD
$32.6B
| $85.4M | 0.12% |
390,700
+261,500
| +202% | +$58.3M |
|
187
Herbalife
HLF
$1.23B
| $84.6M | 0.12% |
6,392,864
-575,884
| -8% | -$7.84M |
|
188
Oneok
OKE
$57.7B
| $84.1M | 0.12% |
1,362,361
+875,400
| +180% | +$54.2M |
|
189
Conagra Brands
CAG
$7.14B
| $83.9M | 0.12% |
2,488,181
-321,919
| -11% | -$11.6M |
|
190
Inspire Medical Systems
INSP
$1.71B
| $83.5M | 0.12% |
257,100
+46,100
| +22% | +$13.2M |
|
|
EA
191
DELISTED
Electronic Arts
EA
| $82.6M | 0.12% |
637,166
+596,066
| +1,450% | +$75.5M |
|
192
Copa Holdings
CPA
$5.49B
| $82.3M | 0.12% |
744,128
+207,800
| +39% | +$20.8M |
|
193
Dick's Sporting Goods
DKS
$18.4B
| $81.8M | 0.12% |
618,500
+78,700
| +15% | +$10.8M |
|
|
PXD
194
DELISTED
Pioneer Natural Resource Co.
PXD
| $81.4M | 0.12% |
+392,804
| New | +$82.7M |
|
195
Baxter International
BAX
$14.3B
| $81.3M | 0.12% |
1,783,900
-1,890,900
| -51% | -$82.3M |
|
196
UiPath
PATH
$8.14B
| $80.2M | 0.12% |
4,839,187
+311,200
| +7% | +$4.99M |
|
197
Aptiv
APTV
$10.3B
| $79.9M | 0.12% |
+782,600
| New | +$77.4M |
|
198
Canadian National Railway
CNI
$76.4B
| $79.8M | 0.12% |
659,100
+68,500
| +12% | +$8.12M |
|
|
GTM
199
ZoomInfo Technologies
GTM
$1.19B
| $79M | 0.11% |
3,110,900
-149,600
| -5% | -$3.54M |
|
|
P
200
Everpure Inc
P
$36.4B
| $78.9M | 0.11% |
2,141,900
+196,500
| +10% | +$5.57M |
|
Similar funds
Jim Simons's Q2 2023 Portfolio in Review
As of Q2 2023, Jim Simons held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Berkshire Hathaway Class A worth $316M.
- Jim Simons's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Jim Simons added most to Apple in Q2 2023, an estimated $856M increase.
- Jim Simons's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Jim Simons fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Jim Simons's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Jim Simons opened 541 new positions and closed 599 in Q2 2023.
- Jim Simons's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.